107 related articles for article (PubMed ID: 21342781)
1. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic.
Tateno F; Sakakibara R; Kishi M; Ogawa E; Terada H; Ogata T; Haruta H
Parkinsonism Relat Disord; 2011 Jun; 17(5):395-7. PubMed ID: 21342781
[No Abstract] [Full Text] [Related]
2. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
3. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
[TBL] [Abstract][Full Text] [Related]
5. From the heart to the brain via cardiac MIBG imaging.
Estorch M
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):246-7. PubMed ID: 16328504
[No Abstract] [Full Text] [Related]
6. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
[TBL] [Abstract][Full Text] [Related]
7. Myocardial metaiodobenzylguanidine tomoscintigraphy for the diagnosis of Lewy body disease in patients with high clinical suspicion and non-diagnostic ioflupane single-photon emission computed tomography.
Le Moine M; Cytryn E; Hambye AS; Bizimungu A; Colson C; Surquin M; Segers K
Psychogeriatrics; 2019 Nov; 19(6):624-625. PubMed ID: 30884066
[No Abstract] [Full Text] [Related]
8. [Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
Kobayashi S; Tateno M; Furukawa Y; Shirasaka T; Utumi K
Seishin Shinkeigaku Zasshi; 2008; 110(4):285-91. PubMed ID: 18593002
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T
Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
11. Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Treglia G; Ceriani L; Giovanella L
Curr Radiopharm; 2014; 7(1):75-8. PubMed ID: 24635146
[TBL] [Abstract][Full Text] [Related]
12. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
Hanyu H; Shimizu S; Hirao K; Sakurai H; Iwamoto T; Chikamori T; Hida S; Yamashina A; Koizumi K; Abe K
Dement Geriatr Cogn Disord; 2006; 22(5-6):379-84. PubMed ID: 16960446
[TBL] [Abstract][Full Text] [Related]
13. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
[TBL] [Abstract][Full Text] [Related]
15. Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.
Kobayashi K; Nakano H; Akiyama N; Maeda T; Yamamori S
Int J Geriatr Psychiatry; 2015 Jun; 30(6):663-8. PubMed ID: 25335897
[TBL] [Abstract][Full Text] [Related]
16. Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.
Kobayashi S; Tateno M; Morii H; Utsumi K; Saito T
Psychiatry Res; 2009 Oct; 174(1):76-80. PubMed ID: 19766460
[TBL] [Abstract][Full Text] [Related]
17. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Yoshita M; Taki J; Yokoyama K; Noguchi-Shinohara M; Matsumoto Y; Nakajima K; Yamada M
Neurology; 2006 Jun; 66(12):1850-4. PubMed ID: 16801649
[TBL] [Abstract][Full Text] [Related]
18. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
19. Improving diagnosis of possible DLB: is there a role for MIBG myocardial scintigraphy?
Ballard C; Grimmer T
Neurology; 2013 Nov; 81(20):1730-1. PubMed ID: 24122184
[No Abstract] [Full Text] [Related]
20. Usefulness of [123I] MIBG myocardial scintigraphy for differential diagnosis of Alzheimer's disease and dementia with lewy bodies.
Kitagawa Y
Intern Med; 2003 Oct; 42(10):917-8. PubMed ID: 14606696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
